Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
Kapa65 / Pixabay

Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C

According to a story from Charcot-Marie-Tooth News, early preliminary testing of a possible gene therapy treatment for a certain type of Charcot-Marie-Tooth disease showed potential in a mouse model. This…

Continue Reading Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C

Loma Linda University Cures Their First Sickle Cell Disease Patient with Stem Cell Transplant

LLUCH Loma Linda University Children's Hospital (LLUCH) is one of six hospitals in the University's health system. They are a faith-based system located in Southern California. They are the only…

Continue Reading Loma Linda University Cures Their First Sickle Cell Disease Patient with Stem Cell Transplant
This Phenylketonuria Patient Helped Test a Breakthrough Therapy Only to Lose Access Once the Trial Ended
source: pixabay.com

This Phenylketonuria Patient Helped Test a Breakthrough Therapy Only to Lose Access Once the Trial Ended

According to a story from BBC, Louise Moorhouse gets the nutrition that she needs through two sources: pills and foul tasting nutrient shakes. This is because she was born with…

Continue Reading This Phenylketonuria Patient Helped Test a Breakthrough Therapy Only to Lose Access Once the Trial Ended

ISMRD International Conference for Glycoprotein Storage Diseases Coming This July

Upcoming Conference The International Society for Mannosidosis & Related Diseases (ISMRD) serves as an international patient advocate for those living with glycoprotein storage diseases. These include alpha-mannosidosis, fucosidosis, mucolipidosis type…

Continue Reading ISMRD International Conference for Glycoprotein Storage Diseases Coming This July
Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis
stux / Pixabay

Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

According to a story from AJC, three year old Reid Peteet is one of over 550 kids that have been diagnosed with acute flaccid myelitis since 2014. 2018 saw a…

Continue Reading Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment

For years FibroGen has been investigating a drug called pamrevlumab. They believe it could be an effective treatment for Duchenne muscular dystrophy (DMD), pancreatic cancer, and idiopathic pulmonary fibrosis (IPF).…

Continue Reading Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment
New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients
Source: Pixabay.com

New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients

Biophosphonates (BPs) are common treatments for osteoporosis and metastatic bone cancer. They help to prevent bone loss. Unfortunately, these drugs can have serious side effects. One of the most severe…

Continue Reading New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients

Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

According to a story from finanzen.at, the biotechnology company Orbsen Therapeutics recently announced that its immunotherapy product ORBCEL-C is to be tested in a multi-site clinical trial called MERLIN that…

Continue Reading Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

Clinical Trial Initiated for New Technology That Could Allow Amyotrophic Lateral Sclerosis Patients to Communicate

People living with rare diseases such as amyotrophic lateral sclerosis (ALS) or muscular dystrophy as well as those who have suffered from a stroke or spinal cord injury often experience…

Continue Reading Clinical Trial Initiated for New Technology That Could Allow Amyotrophic Lateral Sclerosis Patients to Communicate